Therefore, by identifying the conserved gene expression profile shared between HR+ BCa and PCa cell lines that lose hormone receptor accumulation in response to IL-1 and HR− BCa and PCa cell lines that are intrinsically hormone receptor-independent, we have identified putative therapeutic targets alternative to hormone receptors. The gene discussed is IL1B; the disease is posterior cortical atrophy.